Laboratorios Farmaceuticos Rovi SA 2024 AR2
The report details the financial and sustainability performance of Laboratorios Farmacéuticos Rovi, S.A. and its subsidiaries for the fiscal year 2024. Key highlights include the marketing authorization of Risvan (Risperidone ISM) in the United States, although the company decided not to market it there, focusing instead on the European expansion of Okedi. ROVI also completed its Share Buy-Back Programme, cancelling 2,780,395 treasury shares, and entered into a strategic agreement to manufacture pre-filled syringes for a global pharmaceutical company. On the sustainability front, the company implemented an Internal Control over Non-Financial Reporting (ICNFR) system and achieved 100% renewable electricity across all its production complexes and main offices.
Company: Laboratorios Farmaceuticos Rovi SA
Sector: Manufacturing
Country: Spain
Year: 2024
Type: AR2
Pages: 354
Back to company
Laboratorios Farmaceuticos Rovi SA
Annual Accounts And Management Report
The report details the financial and sustainability performance of Laboratorios Farmacéuticos Rovi, S.A. and its subsidiaries for the fiscal year 2024. Key highlights include the marketing authorization of Risvan (Risperidone ISM) in the United States, although the company decided not to market it there, focusing instead on the European expansion of Okedi. ROVI also completed its Share Buy-Back Programme, cancelling 2,780,395 treasury shares, and entered into a strategic agreement to manufacture pre-filled syringes for a global pharmaceutical company. On the sustainability front, the company implemented an Internal Control over Non-Financial Reporting (ICNFR) system and achieved 100% renewable electricity across all its production complexes and main offices.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees